NCT05999942View on ClinicalTrials.gov

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 2, 2004

Primary Completion Date

June 29, 2004

Study Completion Date

June 29, 2004

Conditions
Healthy Volunteers
Interventions
DRUG

Liposomal Amikacin for Inhalation

Administered via the Pari LC STAR™ nebulizer.

All Listed Sponsors
lead

Insmed Incorporated

INDUSTRY

NCT05999942 - A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants | Biotech Hunter | Biotech Hunter